128 related articles for article (PubMed ID: 4377001)
1. Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis.
Rickinson AB; Jarvis JE; Crawford DH; Epstein MA
Int J Cancer; 1974 Dec; 14(6):704-15. PubMed ID: 4377001
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the establishment of Epstein-Barr virus genome-containing lymphoid cell lines from infectious mononucleosis patients: studies with phosphonoacetate.
Rickinson AB; Finerty S; Epstein MA
Int J Cancer; 1977 Dec; 20(6):861-8. PubMed ID: 201573
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: origin of transformed cells arising in co-cultures with foetal lymphocytes.
Rickinson AB; Finerty S; Epstein MA
Int J Cancer; 1977 Jun; 19(6):775-82. PubMed ID: 194845
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic studies on human lymphoblastoid cell lines from Burkitt's lymphomas and other sources.
Jarvis JE; Ball G; Rickison AB; Epstein MA
Int J Cancer; 1974 Dec; 14(6):716-21. PubMed ID: 4377002
[TBL] [Abstract][Full Text] [Related]
5. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
Robinson J; Smith D; Niederman J
Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.
Rickinson AB; Crawford D; Epstein MA
Clin Exp Immunol; 1977 Apr; 28(1):72-9. PubMed ID: 193663
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis.
Crawford DH; Rickinson AB; Finerty S; Epstein MA
J Gen Virol; 1978 Mar; 38(3):449-60. PubMed ID: 204732
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.
Greaves MF; Brown G
Clin Immunol Immunopathol; 1975 Mar; 3(4):514-24. PubMed ID: 163715
[No Abstract] [Full Text] [Related]
9. Epstein-Barr virus: comparison of different strains for their biological activities in vitro.
Furukawa T
Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):543-53. PubMed ID: 166422
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic lymphocytes in infectious mononucleosis.
Osborn DC; Fox RA; Fernandez LA; MacSween JM; Langley GR
Can Med Assoc J; 1976 Dec; 115(11):1118-9. PubMed ID: 187310
[TBL] [Abstract][Full Text] [Related]
11. Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin.
Adams A; Bjursell G; Kaschka-Dierich C; Lindahl T
J Virol; 1977 May; 22(2):373-80. PubMed ID: 194059
[TBL] [Abstract][Full Text] [Related]
12. Origin of lymphoid lines established from mixed cultures of cord-blood lymphocytes and explants from infectious mononucleosis, Burkitt lymphoma and healthy donors.
Dalens M; Zech L; Klein G
Int J Cancer; 1975 Dec; 16(6):1008-14. PubMed ID: 172457
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic potential of Epstein-Barr virus.
Lam KM; Crawford DH
Crit Rev Oncog; 1991; 2(3):229-45. PubMed ID: 1653621
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis.
Rocchi G; Felici A; Ragona G; Heinz A
N Engl J Med; 1977 Jan; 296(3):132-4. PubMed ID: 187934
[TBL] [Abstract][Full Text] [Related]
17. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
18. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients.
Rickinson AB; Moss DJ; Pope JH; Ahlberg N
Int J Cancer; 1980 Jan; 25(1):59-65. PubMed ID: 6249763
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: Observations on the nature of EB-virus infection of peripheral lymphoid cells in infectious mononucleosis.
Rickinson AB; Jarvis JE; Crawford DH; Epstein MA
J Med Microbiol; 1975 May; 8(2):Pxi-Pxii. PubMed ID: 167166
[No Abstract] [Full Text] [Related]
20. Relation between Epstein-- Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt's lymphoma and infectious mononucleosis.
Klein G; Pearson G; Henle G; Henle W; Diehl V; Niederman JC
J Exp Med; 1968 Nov; 128(5):1021-30. PubMed ID: 4878907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
